Author： Cutler D.
Publisher： Elsevier
ISSN： 0165-6147
Source： Trends in Pharmacological Sciences, Vol.22, Iss.10, 2001-10, pp. : 500-501
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Enfuvirtide: the first HIV fusion inhibitor
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 3, 2005-03 ,pp. :
Access to resources
Recommend
TDF an alternative in first-line treatment of HIV infection
Inpharma, Vol. 1, Iss. 1354, 2002-01 ,pp. :
Contending with the challenges of HIV: a first-hand account
Future Virology, Vol. 7, Iss. 7, 2012-07 ,pp. :
First Discovery of Tylophora Alkaloids as HIV Inhibitors
Letters in Drug Design & Discovery, Vol. 12, Iss. 4, 2015-05 ,pp. :
STARTMRK sets pace for raltegravir's first-line finish for HIV
Inpharma, Vol. 1, Iss. 1665, 2008-01 ,pp. :